Basappa, Naveen S. “Treatment Options in Advanced Renal Cell Carcinoma After First-Line Treatment With Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors”. Canadian Urological Association Journal 10, no. 11-12 (December 15, 2016): S242–4. Accessed April 18, 2024. https://cuaj.ca/index.php/journal/article/view/4292.